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Okara oil is a by-product remaining from defatting okara, the solid residue generated after extracting the 
aqueous fraction of grounded soybeans in the elaboration of soy beverages. The goal of this work was to 
encapsulate the probiotic Lactobacillus plantarum CIDCA 83114 into W/O emulsions composed of a block-
copolymer constituted of pluronic® and acrylic acid (PPP12) and okara oil, prepared in microfluidic devices. 
For comparative purposes, alginate was also included as a second dispersed phase. Lactobacillus plantarum 
CIDCA 83114 was suspended in PPP12 or alginate giving rise to dispersed phases with different compositions, 
named I, II, III and IV. Controls were prepared by suspending microorganisms in water as dispersed phase. 6-
carboxyfluorescein was added as bacterial marker in all the emulsions. The presence of green dyed bacteria in 
the dispersed phases, inside the droplets of the emulsions and the absence of fluorescence outside them, 
confirmed the complete encapsulation of bacteria in the dispersed phases. After being prepared, emulsions 
were freeze-dried. The exposure to gastric conditions did not lead to significant differences among the 
emulsions containing polymers. However, in all cases bacterial counts were significantly lower than those of 
the control. After exposing emulsions to the simulated intestinal environment, bacterial counts in assays I, II 
and III (emulsions composed of only one dispersed phase or of two dispersed phases with bacteria resuspended 
in the PPP12 one) were significantly greater than those of the control (p<0.05) and no detectable 
microorganisms were observed for assay IV (emulsions composed of two dispersed phases with bacteria 
resuspended in the alginate one). In particular, bacterial cultivability in emulsions corresponding to assay I 
(only PPP12 as dispersed phase) exposed to the intestinal environment was 8.22±0.02 log CFU/mL (2 log CFU 
higher than the values obtained after gastric digestion). These results support the role of PPP12 as an adequate 
co-polymer to protect probiotics from the gastric environment, enabling their release in the gut, with great 
potential for food or nutraceutical applications.







1H NMR: hydrogen nuclear magnetic resonance
PDMS: poly(dimethylsiloxane)
PBS: phosphate saline buffer
MRS: de Man, Rogosa, Sharpe culture medium





Okara oil is a by-product remaining from defatting okara, the solid residue generated after extracting 
the aqueous fraction of grounded soybeans in the elaboration of soy beverages (Stanojevic, Bara, Pesic et al., 
2013; Scialabba, 2014). It is mainly composed of C18:2 and C18:1 fatty acids, representing altogether ca. 75% 
of the total fatty acids, with lower amounts of C18:3 fatty acid (Quintana, Gerbino, & Gomez-Zavaglia, 2018), 
phytosterols and phenolic compounds (e.g., isoflavones, genistein, daidzein). Because of their nutritional 
relevance, okara oil components can be recovered and applied in the cosmetic, pharmaceutical and food 
industries (Quitain, Oro, Kato et al., 2006; Borhan, Gani, & Shamsuddin, 2014; Quintana, Gerbino & Gomez-
Zavaglia, 2018) for drug delivery, butter production, salad dressing or in the formulation of pharmaceutical or 
food emulsions (Quintana et al., 2018; Latheef, 2012).
Lactic acid bacteria are extensively used as starters in the development of food and probiotic products. 
The increasing demand of the food industry for functional foods containing probiotic bacteria underlines the 
need of implementing appropriate processes ensuring bacterial counts fitting the requirements of the 
international regulation organisms [e.g., EFSA, FDA >6-7 log colony forming units (CFU)/g] (Aquilina, Bach, 
Bampidis et al., 2013). Encapsulation of probiotics is an extended strategy to maintain their mechanical 
integrity during production (e.g., oxidation, shear, exposure to high/low temperatures) and dehydration 
processes (packaging and environmental conditions, including moisture, oxygen, temperature, etc), as well as 
when exposed to gastro-intestinal conditions (Heidebach, Först, & Kulozik, 2010; Sandoval-Castilla, Lobato-
Calleros, Garcia-Galindo et al., 2010). The encapsulation of probiotic bacteria into emulsion droplets of 
different compositions (Pimentel-Gonzalez, Campos-Montiel, Lobato-Calleros et al., 2009) followed by 
dehydration (e.g. freeze-drying, spray-drying) has been successfully used to stabilize different bacterial strains 
(Rokka & Rantamäki, 2010; Zhang, Lin, & Zhong, 2015; Rodriguez-Huezo, Estrada-Fernandez, Garcia-
Almendarez et al., 2014) into microcapsules of different types and sizes (Champagne & Fustier, 2007).
Among the methods employed to prepare emulsions, microfluidic technology allows the control of small 
amounts of fluids through micrometer-scale channels, enabling the production of droplet-based biomaterials 
(Francesko, Cardoso, & Lanceros-Mendez, 2019). It offers an alternative and versatile way to obtain emulsions 
with an exquisite control over the size, number and properties of each droplet, which are formed one-by-one 
(Utada, Lorenceau, Link et al., 2005; Chu, Utada, Shah, et al., 2007). Microfluidics has been used for the 
preparation of monodispersed vesicles constituted of particles with different internal structures or for precisely 
incorporating specific materials inside emulsions (Vinner, Vladisavljević, Clokie, et al., 2017; Bazban-
Shotorbani, Dashtimoghadam, Karkhaneh et al., 2016; Håti, Basssett, Ribe et al., 2016; Marquis, Davy, 
Cathala, et al., 2015). As microfluidic devices have micrometrical dimensions comparable to the size of cells, 
this approach represents an invaluable tool to investigate complex cellular systems (Niu & de Mello, 2012). In 
spite of that, no attempts have been made to use it for the encapsulation of lactic acid bacteria.
Taking advantage of microfluidic devices, using them for encapsulating probiotic bacteria would not 
only allow their incorporation into the droplets with greater accuracy, but it would also offer the possibility of 
incorporating additional materials to better protect microorganisms during the processing and exposure to 
gastro-intestinal conditions. In this respect, the incorporation of probiotics into polymers that are not 
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hydrolyzed along the gastro-intestinal tract (e.g., pectins, inulin, synthetically engineered polymers) represents 
an important advantage to enable their safe arrival to their target, that is, the gut (Ghibaudo, Gerbino, Copello 
et al., 2019; Ghibaudo, Gerbino, Hugo et al., 2018; Ghibaudo, Gerbino, Campo Dall´Orto et al., 2017; Cassani, 
Gomez-Zavaglia & Simal-Gandara, 2020). Poly(acrylic acid) (PAA) is a biocompatible and biodegradable 
anionic polyelectrolyte (pKa: 4.95), and pluronic® (PLU) is composed of triblock copolymers of poly(ethylene 
oxide) (PEO) and poly(propylene oxide) (PPO) (PEO–PPO–PEO) (Figure 1). The pluronic PEO block is 
hydrophilic and water soluble while the PPO block is hydrophobic and water insoluble, thus giving Pluronics 
an amphiphilic attribute (Quintana, Simões, Hugo et al., 2017). PAA-PLU-based co-polymers (PPP) have 
demonstrated to overcome gastro-intestinal environment without decomposing because of the amphiphilic 
properties of PLU and the resistance of PAA to the acid gastric environment. For this reason, they have been 
used for the controlled release of drugs whose target is the gut (Barreiro-Iglesias, Bromberg, Temchenko et 
al., 2005; Kabanov, Batrakova, & Alakhov, 2002). Besides such structural and physiological advantages, PPP 
is less viscous than other biocompatible polymers, which can facilitate the preparation of emulsions in 
microfluidic devices. In spite of these advantages, PPP has been scarcely used to encapsulate probiotics, whose 
target is also the gut (Quintana et al., 2017; Feng, Wei, Hu et al.,  2020; Seifert, Kashi & Livney, 2019).
Taking into account the importance of adding value to okara oil, the precision of microfluidics for the 
formulation of emulsions, and the structural and physiological advantages of PPP, the goal of this work was 
to encapsulate the probiotic strain Lactobacillus plantarum CIDCA 83114 into O/W emulsions composed of 
okara oil and PPP. To achieve this goal, four different compositions of emulsions have been prepared using 
microfluidic devices, and then, freeze-dried. As alginate is generally used as dispersed phase in microfluidic 
devices, it was also employed as a second dispersed phase to compare the encapsulating capabilities of PPP 
(Campaña, Sotelo, Oliva et al., 2020; Håti, Basssett, Ribe et al., 2016; Marquis, Davy, Cathala, et al., 2015; 
Chen, Kim, Zhang et al., 2013; Ma, Pacan, Wang et al., 2012; Kalvanaraman, Retterer, McKnight et al., 2009). 
The efficiency of encapsulation and the droplets' size were determined by optical and fluorescence microscopy. 
The protective effect of PPP on microorganisms was assessed after exposing the emulsions to simulated gastro-
intestinal conditions. 
2. MATERIALS AND METHODS
2.1. Materials
Okara was obtained from Soyana S.H. (San Martín, Argentina); low fat milk (Difco, NJ, USA); MRS 
broth (Biokar Diagnostics, Paris, France); agar (Parafarm, Buenos Aires, Argentina); potassium chloride 
(Anedra, Buenos Aires, Argentina); sodium bicarbonate (Biopack, Buenos Aires, Argentina); calcium chloride 
(Panreac, Barcelona, Spain); sodium biphosphate (Anedra, Buenos Aires, Argentina); potassium biphosphate 
(J.T. Baker, NJ, USA); magnesium chloride (Riedel-de Haen, Heidelberg, Germany); hydrochloric acid (Fisher 
Scientific, Waltham, MA, USA); petroleum ether (Biopack, Buenos Aires, Argentina); ethyl ether (Biopack, 
Buenos Aires, Argentina); hexane (VWR Chemicals, Radnor, PA, USA), elastomer (SYLGARDTM 184 
Silicone Elastomer Base, Midland, MI, USA); curing agent (SYLGARDTM 184 Silicone Elastomer Curing 
Agent, Midland, MI, USA); lecithin (Scharlab, Barcelona, Spain); sodium alginate (Alfa Aesar, Tewksbury, 
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MA, USA); 6-carboxyfluorescein (Fluka, BioChemika, Barcelona, Spain); fine-caliber polyethylene tubing 
(Portex, Smiths medical, Keene, NH, USA). All the following reagents were from Sigma-Aldrich (St. Louis, 
MO, USA): sodium chloride, ammonium chloride, mucin (Type II), pepsin (P7125), pancreatin (P1625), lipase 
(Type II), bile salts (P48305), Pluronic acid F68, acrylic acid, Tween 80, lauroyl peroxide, 4,4'-azobis (4-
cyanovaleric acid), nonane and trichloro (1H,1H,2H,2H-perfluorooctyl)silane.
2.2. Methods
2.2.1. Extraction of oil from okara
Once received, okara was centrifuged 5 times to remove the excess of water. The solid sediment was 
frozen at -80°C for 48 hours and freeze-dried in a Heto FD4 (Heto Lab Equipment, Denmark) equipment for 
48 hours (temperature of the condenser: -50°C; chamber pressure: 0.04 mbar). Okara oil was extracted with 
diethyl ether solvent (boiling point 34.6 °C) for 2 hours in a Soxhlet system (AOAC, 1995).
2.2.2. Synthesis of PPP copolymer
PPP was synthesized through polymerization by emulsion, according to Choo & Xue (2011) and 
Quintana et al. (2017). The reaction scheme is presented in Figure 1. Briefly, PLU F68 was dissolved in acrylic 
acid by addition of 0.5 mL of 5 M NaOH under constant shaking in a nitrogen stream. Acrylic acid was 
proportionally added taking into account the number of –OH terminal groups in PLU to obtain a copolymer 
with equal number of acrylic acid repeating units. Hundred mg of lauryl peroxide and 100 mg of 4-azobis-(4-
cyanovaleric acid) were dissolved in 5 mL of acrylic acid, and then incorporated into the PLU solution. This 
final solution was introduced into a 500 mL round bottom 3-necked flask with 250 mL of Tween 80 solution 
in nonane (1% v/v) previously deoxygenated, for 1 hour under a constant nitrogen flow. The reaction was 
carried out at 70 °C for 10 hours. The obtained polymer, named PPP12, was washed in hexane and water to 
remove impurities, and dried in a vacuum oven at 40 °C for 48 hours. It was characterized by 1H NMR using 
a Bruker Avance III 400 MHz spectrometer (Quintana et al., 2017), with theoretical molecular weight of 12 
kDa.
2.2.3. Bacterial strain and culture conditions
Lactobacillus plantarum CIDCA 83114 was isolated from kefir grains (Garrote, Abraham, & De Antoni, 
2001) and preserved at -80°C in 120 g/L of non-fat milk solids. Microorganisms were cultured twice in MRS 
broth (de Man, Rogosa, & Sharpe, 1960) at 37 ºC in aerobic conditions because of its microaerophilic character 
(Quintana et al., 2018). Cultures in the stationary phase (~1×1011 CFU/mL) were harvested by centrifugation 
at 8000 rpm (Hermle Centrifuge Z 326 K, Gosheim, Germany) for 10 minutes, washed twice with phosphate 
saline buffer (PBS, KH2PO4 0.144 g/L, NaCl 9 g/L, Na2HPO4 0.795 g/L, pH 7.2) and suspended in the 
corresponding dispersed phase (PPP12 or alginate as explained in section 2.2.5.2 and Table 1) or in PBS (non-
emulsified microorganisms), in the same volume as the original bacterial culture.
2.2.4. Building of microfluidic device (chips)
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Microfluidic chips are micro-channels etched or molded into a material (elastomer), connected together 
to achieve the desired features of the fluids. For the fabrication of the poly(dimethylsiloxane) (PDMS) devices 
used in this work, a mixture of PDMS (PDMS, Sylgard 184) and cross-linker (ratio 10:1, w/w) were thoroughly 
mixed and further placed in a desiccator connected to a vacuum pump. Once completely degassed, the material 
was poured over a Petri dish where a master with the appropriated channel structure (obtained by soft 
lithographic techniques and kindly donated by Dr H. van Vliet from Delft University of Technology, 
Netherlands) was sealed. After a second degassing, the mold was covered and placed overnight in a stove at 
65 °C for the curing process. After cooling down the molds to 25 °C, the area surrounding the quadrant, where 
the chips were located, was carefully peeled off with a scalpel. One mm diameter holes were drilled with a 
retractable hole puncher (50 or 200 µm) to define the inlet and outlet points. Finally, the chips were joined to 
a microscope glass slide and sealed with oxygen plasma in a clean room at the Autonomous University of 
Madrid (Spain) and flowed with trichloro (1H,1H,2H,2H-perfluorooctyl)silane in fluorinated oil HFE-7500 
(1%, w/w; 3M) to provide a channel with hydrophobic surfaces (Zinchenko, Devenish, Kintses et al., 2014). 
After that, the chips were ready-to-use (Figure S1).
2.2.5. Formulation of emulsions
2.2.5.1. Assembling of equipment. Chips with 50 or 200 µm internal diameter channels and two inlet and one 
outlet (Figure S1A), and three inlet and one outlet points (Figure S1B) were used for generating the water-in-
oil emulsions (W/O). The composition of the continuous and dispersed phases used for the different assays is 
shown in Table 1. Both the continuous and dispersed phases were injected with glass syringes (1 mL and 100 
µL, respectively) using Nemesys Apparatus pumps controlled through a Nemesys software (Nemesys 
Interface, Madrid, Spain). Capillary polyethylene tubes (internal diameter: 0.38 mm) were used to connect the 
syringes to the chips' inlet and outlet points. W/O emulsions were collected off-chip. The formation of the 
emulsions in the chips was monitored in real time in an optical microscope (Optika, Ponteranica, Italy) 
connected to a "pike" camera using Vimba software (Vimba v3.1 ARM64, Germany).
2.2.5.2. Preparation of water/oil (W/O) emulsions. Okara oil containing 4% (w/v) of lecithin (incorporated as 
emulsifier) was used as continuous phase in all the assays. PPP12 prepared at 2% (w/v) in 0.5 M NaCl (pH 6) 
and sodium alginate prepared at 1.5% (w/v) in distilled water were used as dispersed phases. As mentioned in 
section 2.2.3, L. plantarum CIDCA 83114 was suspended in the dispersed phases. 6-carboxyfluorescein (CF, 
0.5 µM) was used as marker of the emulsions (Table 1). 
2.2.6. Freeze-drying process and plate counting
The freshly obtained emulsions were frozen at -80 °C for 48 hours, freeze-dried in a Lyoquest -85 
equipment (Telstar Technologies, S.L., Spain) at a continuous temperature of -85 °C for 48 hours, and stored 
at 4 °C in silica gel containing recipients. Non-emulsified microorganisms (section 2.2.3) were freeze-dried in 
PBS in the same conditions.
Microorganisms contained in the emulsions were plate counted before and after freeze-drying. To this 
aim, samples (powders) were rehydrated in PBS and then, serially diluted in PBS, plated on MRS agar and 
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incubated at 37 oC in aerobic conditions for 48 hours. Non-dehydrated bacteria (fresh cultures harvested and 
not freeze-dried) were directly diluted in PBS and plate counted as for freeze-dried ones. Results were 
expressed as log CFU/mL.
2.2.7. Fluorescence microscopy and droplets' size
Before and after freeze-drying, the emulsions stained with 6-carboxyfluorescein were observed in a 
fluorescence microscope (Nikon Model Eclipse TS100LED-F MV, Germany) using Vimba software (Vimba 
v3.1 ARM64, Germany). Fast Read 102R plates composed of 10 counting chambers were used to observe the 
emulsions' droplets and determine their size (Fiji software, Madison, Java8, Germany) (Figure S2). An average 
of not less than 50 determinations was reported.
2.2.8. Simulated gastrointestinal digestion
After freeze-drying, the emulsions were digested in simulated gastrointestinal solutions (emulsion:fluid 
ratio = 1), according to Quintana, Spinola, Martins, et al. (2020). The detailed composition of digestive juices 
(gastric, intestinal and bile) is provided in Table 2. The process was divided into two stages, gastric and 
intestinal digestion. For experimental convenience, samples were divided into two batches, one of them only 
exposed to gastric digestion and the other one, exposed to the whole digestive process, and then used to perform 
determinations. The digestion process was executed as follows: both experimental batches of samples (assays 
I, II, III, IV and control; Table 1) were suspended in 1 mL of gastric solution and incubated for 2 hours at 37 
°C under continuous shaking (190 rpm, MaxQ 4000, Thermo Scientific, USA), protected from light. Samples 
were then centrifuged at 4000 rpm for 10 minutes at 25 ºC to enable bacteria sedimentation. One of the sample 
batches was washed with PBS and kept for plate counting, and the second one was exposed to the simulated 
intestinal environment. To simulate the intestinal fluid, 0.5 mL of duodenal solution and 0.5 mL of biliary 
solution were added to the gastric digested emulsions (Table 2) and incubated for 2 hours at 37 °C under 
continuous shaking (190 rpm, MaxQ 4000, Thermo Scientific, USA). After that, samples were centrifuged 
again at 4000 rpm for 10 minutes at 25 ºC, and the bacterial pellets were washed once with PBS.
After each digestion stage, the samples were serially diluted in PBS and microorganisms were plate 
counted as described in section 2.2.6. Results were expressed as log CFU/mL.
2.2.9. Statistical analysis
All experiments were conducted in triplicate and on independent bacterial cultures. Average values were 
used for data analysis. Analysis of variance (ANOVA) was carried out for all the assays, using the statistical 
program InfoStat 2008 (Infostat Group/FCA. National University of Cordoba. Ed. Brujas, Cordoba, 
Argentina). Comparison of means was tested using Tukey's method, and if p<0.05, the difference was 
considered statistically significant.
3. RESULTS AND DISCUSSION
3.1. Formulation of W/O emulsions in microfluidic devices
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The size of the inlet and outlet points of the chips was of great importance to formulate emulsions. Using 
50 µm diameter chips led to major experimental limitations, mainly arising from obstruction problems due to 
the high viscosity of the continuous phase and dispersed phases (data not shown). For this reason, experiments 
were set-up using 200 µm diameter chips. This posed several advantages over the smaller ones, including the 
possibility of using greater flow rates and higher concentrations of PPP12, alginate and lecithin, the possibility 
of simultaneously using more than one polymer (e.g. PPP12 and alginate), and the avoidance of obstruction 
problems, thus enabling the re-utilization of chips. Table 1 depicts the flow rates and flow rate ratios of the 
dispersed and continuous phases employed in the different assays (I, II, III, IV and control). PPP12 and alginate 
were used in the highest concentrations enabling the work without experimental limitations arising from 
obstruction problems associated to the use of viscous solutions in microfluidic devices. Considering the 
emulsifying role of lecithin, the concentration used was that allowing a perfect dilution in the okara oil. In 
these experimental conditions, stable and uniformly size droplets were regularly generated, as determined by 
direct microscopic observation.
At the flow rates reported in Table 1, a steady flow of droplets in the T-junction (contact point of the 
continuous and dispersed phases) was achieved (Figure 2, images on the left -a-), and these droplets were 
transported through the channel of the chip to the outlet point (Figure 2, images on the right -b-). 
The composition of the emulsions and the flow rates of the continuous and dispersed phases determined 
the cutting forces of the droplets at the moment of its formation (Vinner et al., 2017), which ultimately 
determined the characteristics of the emulsions formulated in the four assays. For alginate containing 
emulsions a longer dispersed phase was observed at cutting point (where the droplets are formed) (Figure S3). 
This behavior results from the high flow rates of the dispersed phase compared to those of the continuous 
phases, which prevents the continuous phase to break up the flow and form droplets (Figure S3). Besides the 
flow rates, the concentration of alginate can also cause the extension of the dispersed phases (Vinner et al., 
2017; Mazutis, Vasiliauskas, & Weitz, 2015).
To avoid an extension of the disperse phase in alginate containing emulsions, different flow rate ratios 
had to be settled taking into account the composition of the disperse phases (Table 1). Three different flow rate 
ratios were settled for emulsions prepared in devices with two inlet points (assay I, III and control). The 
different viscosity of PPP12 and alginate strongly determined the set-up of a flow rate enabling a steady flow 
of droplets formation. In assay III (dispersed phase containing just alginate), a lower dispersed/continuous flow 
rates ratio (1:10) was required to enable droplets formation. In the control, the dispersed phase (water) did not 
have the same viscosity of alginate or PPP12 solutions, and the flow rate ratio was not a determinant factor to 
achieve a steady flow of droplets formation. Other authors also reported that changing the flow rates of 
dispersed and continuous phases leads to changes in the droplets' size (Eun, Utada, Copeland et al., 2011; 
Utech, Prodanovic, Mao et al., 2015).
For emulsions prepared in devices with three inlet points (assays II and IV) the same flow rate ratio was 
settled (1:6) regardless the composition of the dispersed phases (PPP12 or alginate), and regardless the polymer 
in the internal dispersed phase containing microorganisms. When increasing the flow rate of the dispersed 
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phase or decreasing that of the continuous phase, an extension of the dispersed phase was also observed (Figure 
S3).
Figure 3 depicts the images of fresh W/O emulsions obtained using microfluidic devices. The emulsions' 
droplets had spherical shapes surrounded by a ring in all the assays (I, II, III, IV). That ring was particularly 
evident in assays II and IV, probably due to the use of two different dispersed phases. The control showed 
steady and spherical droplets as well, but just surrounded by a thin crust (Figure 3C). L. plantarum CIDCA 
83114 was observed in the dispersed phases of the emulsions (red arrows in Figure 3). The absence of bacteria 
outside the emulsions confirmed their correct encapsulation. The labelled emulsions looked like pretty similar 
and Figure 3F shows a representative image (corresponding to the control) without bacteria outside, which 
confirmed this observation. Other authors also reported similar rings surrounding the droplets of microfluidics-
obtained emulsions and the absence of microorganisms outside them, although the composition of such 
emulsions was different (Barlow, Gozzi, Kelley et al., 2017; Eun et al., 2015).
Figure 4 shows the size of the droplets corresponding to assays I, II, III, IV before and after freeze-
drying. The droplets corresponding to fresh emulsions were within 143 and 180 µm (gray bars, Figure 4) and 
no significant differences were observed among assays (I, II, III, IV) nor in the control. The droplets 
corresponding to the emulsions after freeze-drying were within 156 and 208 µm (dashed bars, Figure 4). No 
significant differences were observed for the droplets' size before and after freeze-drying, except for assay IV 
and for the control. Dehydration involved in the freeze-drying process could explain the increase in the control 
droplets' size because the removal of water in the absence of emulsions makes them prompter to aggregate. 
The increase in droplet size of assay IV follows the same principle. Samples corresponding that assay were the 
only ones composed of two dispersed phases, PPP12 being the last to be incorporated. The 
dehydration/hydration process changes the surrounding environment (salts concentration, pH) and therefore 
the polymer conformation, primarily of the PAA segment and concomitantly of the PPP as a whole, thus 
possibly contributing to change the droplet size.
3.2. Simulated gastro-intestinal digestion
In order to avoid thermal treatment with unknown effect on the polymers used, freeze-drying was 
selected as dehydrated method for the obtained emulsions, as it does not have negative effects on the polymers 
employed (Quintana et al., 2017). The protective effect of polymers on microorganisms was evaluated by 
determining the bacterial release after exposing the freeze-dried W/O emulsions (I, II, III, IV, control) to 
simulated gastro-intestinal conditions. 
Figure 5 shows the log CFU/mL before and after each digestion stage. Before digestion, bacterial 
viability in polymers' containing emulsions was significantly lower than that corresponding to the control 
(9.28±0.06 log CFU/mL) (gray bars in Figure 5). After exposure to gastric conditions, bacterial counts for the 
control were significantly lower than those before digestion (p<0.05) but still greater than those corresponding 
to assays I, II, III and IV (p<0.05) (white bars in Figure 5). No significant differences in bacterial counts were 
observed among polymers' containing emulsions after exposure to gastric conditions (p>0.05).
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After exposing the emulsions to the simulated intestinal environment, bacterial counts in assays I, II and 
III were significantly greater than those of the control (p<0.05) (dashed bars in Figure 5). No detectable 
microorganisms were observed for assay IV (containing two dispersed phases). The most remarkable result 
was that obtained for assay I (bacterial suspended in PPP12, Table 1). In assay I, bacterial counts were 
significantly higher than those observed for the other two assays (II and III). In fact, bacterial cultivability in 
assay I emulsions exposed to the intestinal environment was 8.22±0.02 log CFU/mL, that is, ca. 2 log CFU 
higher than the values obtained after gastric digestion. This indicates that PPP12 used as only dispersed phase 
resulted in the best formulation to protect microorganisms from gastric conditions and enable their release in 
the gut. The high concentration of released bacteria in assay I fits well within the requirements of the 
international organisms (EFSA, FDA) regarding probiotic containing products, stated as at least 6-7 log CFU 
of viable microorganisms per gram of product at the moment of being consumed (Aquilina et al., 2013). 
In a previous work, it was pointed out that the bacterial surface has a negative charge (Quintana et al., 
2017). It is therefore interesting that the first layer of polymer placed on these has a positive charge, to favor 
the stability. In gastric conditions, pH (ca. 3) was close to the pKa values of both polymers (PPP12, pKa= 4.95 
and alginate pKa=3.5) (Cook, Tzortzis, Khutoryanskiy et al., 2013; Alves, Hugo, Tymczyszyn et al., 2013), 
but more so for alginate. This means that, at gastric pH, PPP12 has a higher percentage of positive charges 
than alginate. Therefore, the emulsions in which PPP12 was immediately deposited over bacteria should be 
more stable, as the repulsion should be lower. This explains the good results for the assay I, which allowed the 
retaining of more viable bacteria during the gastric phase than the other assays (Figure 5).
However, the result was not the same when alginate was incorporated as a second polymer, despite 
PPP12 was again immediately deposited over bacteria (assay II). Electrostatic repulsion between these two 
positively charged polymeric layers could generate a less stable emulsion reducing the number of viable 
bacteria reaching the gastric phase (Figure 5). This effect was more accentuated when alginate was used as the 
first layer and PPP12 as the second one (assay IV). In this case the repulsion between polymers is combined 
with a certain repulsion between the negative charges of the alginate (about 24% of the charges at pH 3) and 
those of the bacterial surface. Hence, the low counts observed for the assay IV in the intestinal phase (Figure 
5). At intestinal pH (ca. 8.5), both polymers were negatively charged (>99%), and thus, the high electrostatic 
repulsion destabilized the emulsions, enabling the release of viable bacteria to this phase. Other authors also 
reported electrostatic repulsions in capsules composed of soy protein isolates and alginate exposed to different 
pH (Hadzieva, Mladenovska, Crcarevska et al., 2017), thus supporting the explanation provided above. In line 
with this explanation, Vinner et al., (2017) reported that by combining the pH responsive character of 
Eudragit1with alginate, phage CDKM9 was significantly protected from exposure to simulated gastric fluid at 
pH 2 and could thereafter be readily released upon exposure to pH 7. Duan, Lü, Gao, et al. (2016) found that 
the Eudragit1S100 coating enables resistance to the acidic environment of the stomach, whilst alginate 
provides muco-adhesive properties which prolong the residence time of microparticles in the body. Similar 
investigations carried out by Sookkasem, Chatpun, Yuenyongsawad et al. (2015) showed the release of 
curcumin in simulated intestinal fluid at pH 7.4.
12
4. CONCLUSIONS
Using microfluidic devices to formulate emulsions and encapsulate probiotic microorganisms brings 
several attractive advantages and a new perspective from economic, technological and environmental point of 
view in the food industry. In this context, this work proposed an innovative approach to add value to okara oil 
as continuous phase, enabling an appropriate control on the formation of emulsion droplets. In addition, using 
PPP12 as dispersed phase of emulsions provided an interesting system to control probiotic deliver to the gut, 
ensuring a bacterial release fitting the requirements of international organisms for probiotic containing 
products. The key role of this polymer also provided strong support for the application of PLU based co-
polymers beyond intestinal drug delivery. The results obtained in this work constitute a promising contribution 
for the implementation of strategies originally developed for the pharmaceutical industry in the 
food/nutraceutical industries. Further investigations will be necessary to better characterize the particles and 
study their stability under different environmental conditions providing new strategies for their implementation 
at an industrial level.
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Captions to figures
Figure 1. Reaction scheme for the synthesis of PAA-PLU-PAA (PPP). x = number of ethylene oxide units; 
y = number of O-CH3-CH2 units; z = number of propylene oxide units, m, n = number of acrylic 
acid units.
Figure 2. Microscopic images from W/O emulsions obtained using microfluidic devices. White arrows 
represent the entrance of the dispersed phase; black arrows, the input of the continuous phase; red 
arrows indicate the input of dispersed 1 phase in emulsions II and IV (see Table 1 for definition). 
a indicates T-junctions of the two phases, and b: end point before the outlet. A scheme of the 
devices is shown on the right part of the figure.
A. Chips having two inlet (denoted as 1 and 2 in the scheme on the right) and one outlet (denoted 
as 3) points (used in assays I, III and control);
B. Chips having three inlet (1, 2, 3) and one outlet (4) points (used in assays II and IV).
Figure 3. Microscopic images of W/O emulsions containing L. plantarum CIDCA 83114. I, II, III, IV 
represent the different assays defined in Table 1. C: control, F: CF labeled emulsions. Red arrows 
denote encapsulated microorganisms. Images corresponding to samples I, II, II, IV and C were 
taken with a 40× magnification, and image corresponding to F, with a 20× magnification. Red circle 
in script C denotes the crust.
Figure 4. Droplet size of W/O emulsions obtained using microfluidic devices. Gray bars: fresh emulsions; 
dashed bars: emulsions after freeze-drying. An average of 50 determinations is plotted. Different 
letters indicate statistically significant differences (p˂0.05).
Figure 5. Bacterial release after exposing freeze-dried W/O emulsions to simulated gastro-intestinal 
conditions. Gray bars: before digestion, white bars: after exposure to the gastric environment, 
dashed bars: after exposure to intestinal digestion. Different letters indicate statistically significant 
differences (p˂0.05). *no growth. Bacterial viability before freeze-drying (average all assays): 
11.56±0.34 log CFU/mL; viability for microorganisms freeze-dried in PBS (non-emulsified):  
5.43±0.42 log CFU/mL.
Supplementary material
Figure S1.Scheme of the different chips used in this work:
A. Chip with two inlet points. I1: Inlet point of the continuous phase; I2: Inlet point of the dispersed 
phase; O: Outlet point;
B. Chip with three inlet points. I1: Inlet of the continuous phase; I2: Outlet of the first dispersed 
phase 2; I3: Inlet of the second dispersed phase 1; O: Outlet point.
In the middle, a picture of the chips.
Figure S2.A. Fast Read 102 plate consisting of 10 counting chambers to observe emulsions;
B. Fast Read plate gang allowing the measurement of emulsions inside the quadrant.
Figure S3.  Extension of the dispersed phase in:
A. emulsions containing alginate;
B. emulsions not containing alginate.
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Table 3. Volumetric ratio of the dispersed and continuous phases in the emulsions for 







Dispersed L.  plantarum CIDCA 83114 in water + CFb 120
Control
Continuous Okara oil+lecithin 960
1:8
Dispersed L. plantarum CIDCA 83114 in PPP12c + CF 120
I
Continuous Okara oil+lecithin 600
1:5
Dispersed 1 L. plantarum CIDCA 83114 in PPP12 + CF 40
Dispersed 2 Alginate 60II
Continuous Okara oil+lecithin 600
1:6
Dispersed L. plantarum CIDCA 83114 in alginate + CF 60
III
Continuous Okara oil+lecithin 600
1:10
Dispersed 1 L. plantarum CIDCA 83114 in alginate + CF 40
Dispersed 2 PPP12 60IV
Continuous Okara oil+lecithin 600
1:6
aWhen using lecithin, PPP12 and alginate, their concentrations were 4% w/v, 2% w/v and 1.5 
w/v, respectively. 
bCF: carboxyfluorescein.
c PPP12: block-copolymer of ca. 12 kDa constituted of pluronic® and  poly(acrylic acid).
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Table 2. Composition of simulated gastrointestinal juices
Stock solutions Gastric Duodenal Bile
Distilled water (mL) 100 100 100
NaCl (g) 0.55 1.40 1.05
KCl (g) 0.16 0.11 0.08
NaHCO3 (g) - 0.68 1.16
CaCl2.H2O (g) 0.08 - -
NaH2PO4 (g) 0.053 - -
KH2PO4 (mg) - 16.06 -
NH4Cl (g) 0.061 - -
MgCl2 (mg) - 10.08 -
Urea (g) 0.02 0.02 0.05
Concentrated HCl (mL) 1.30 0.03 0.03
0.50 pepsin 1.80 pancreatin 2.40 Bile salts
Adjuncts (g)
0.60 mucin 0.30 lipase




► Okara oil, PPP12 and alginate were used to prepare emulsions in microfluidic devices ►L. plantarum was 
suspended in four different dispersed phases and freeze-dried ► No significant differences in bacterial viability 
were observed in gastric conditions ► Using PPP12 as only dispersed phase protected bacteria from gastric 
conditions ►At the same time, such conditions enabled the greatest bacterial release in the gut
